NEW YORK / RankWire.AI / – U.S. stocks saw modest improvements on Wednesday amid a sharp decline in long-term Treasury yields. The S&P 500 increased by 16.22 points, or 0.21%, reaching 7,707.98 and ending a streak of three consecutive losing sessions. The Dow Jones Industrial Average added 119.65 points, or 0.22%, closing at 53,463.05. The Nasdaq Composite rose by 41.38 points, or 0.16%, finishing at 26,331.09. The decline in government bond yields helped the major indexes recover after days of downward pressure caused by rising borrowing costs.
Bond prices advanced following the U.S. Treasury Department’s announcement of increased liquidity support buybacks for longer-term government debt. Starting September 9, the maximum purchase amount per operation will rise from $2 billion to a minimum of $4 billion. This change applies to nominal coupon securities in the 10-to-20-year and 20-to-30-year maturity categories. The expanded buyback program will remain in effect until November 4. The department explained that robust volumes of high-quality offers supported the decision to boost liquidity operations in these sectors.
Following the announcement, Treasury yields retreated, reversing part of their recent upward trend in long-term borrowing costs. The 10-year Treasury yield decreased to approximately 4.65%, while the 30-year yield dropped to about 5.20%. On Tuesday, the 30-year yield reached 5.337%, its highest point since 2007. Since bond yields move inversely to prices, increased demand for government debt led to the decline in yields. This pullback alleviated some of the pressure that had built during the recent selloff of long-term government bonds.
Healthcare Sector Bolsters Market Positivity
Healthcare stocks contributed positively during Wednesday’s trading, with several pharmaceutical companies posting substantial gains. Moderna shares surged 177%, while Merck advanced 12.6%, following the release of positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene combined with Keytruda after surgical removal of high-risk melanoma. The trial met its primary endpoint of recurrence-free survival and also achieved a key secondary endpoint that measured survival without distant cancer spread.
This rally in healthcare equities helped offset mixed results elsewhere, especially in technology sectors. Consumer stocks also contributed to the gains after several major corporations reported quarterly earnings during the session. Estée Lauder’s shares jumped over 16% following its earnings report, further boosting consumer sector performance. Target and Lowe’s also saw increases after releasing their latest financial results. Smaller-cap companies outperformed large caps overall, with the Russell 2000 rising around 0.5% as the broader market staged a recovery.
Indexes End Three-Day Losing Streak
Wednesday’s gains marked the end of a three-session decline for the Nasdaq, the S&P 500, and the Dow. The rebound followed earlier-week pressure from rising long-term yields that weighed heavily on equities. Despite Wednesday’s positive move, the major indexes remained lower for the week. The S&P 500 was roughly 1% below last Friday’s level. The Dow had declined approximately 0.5%, while the Nasdaq was about 1.5% down for the week.
Looking at the broader year-to-date performance, the indices still maintained a positive outlook despite this week’s setbacks and recent bond market challenges. As of Wednesday’s close, the S&P 500 had gained roughly 12.6% since the start of the year. The Dow was up about 11.2%, and the Nasdaq outperformed with an increase of around 13.3%, reflecting its stronger year-to-date progress. Wednesday’s session thus represented a modest recovery for Wall Street, supported by falling Treasury yields and healthcare sector advances that lifted all three major U.S. stock indexes.